Physician profile
Daniel James Patrick Burns
NPI 1659850717
$8,671.01
in general payments reported to CMS, 2019-2025
12 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,620 · 2020: $717 · 2021: $303 · 2022: $2,140 · 2023: $652 · 2024: $655 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526 · Consulting Fee: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.65 |
| Consulting Fee | $366.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,203.08 | 2019-2024 | |
| Abbott Laboratories | $2,549.16 | 2019-2025 | Epic |
| Medtronic Vascular, INC. | $2,037.08 | 2019-2020 | |
| Corcym INC | $349.81 | 2022-2024 | Perceval |
| Dilon Technologies, INC. | $183.17 | 2024-2025 | Hemoblast Bellows |
| Atricure, INC. | $124.70 | 2019-2022 | |
| Ethicon US, LLC | $109.36 | 2019-2021 | |
| Supreme Orthopedic Systems, LLC | $42.29 | 2025 | |
| Nexus Medical Technologies LLC | $33.38 | 2025 | |
| Abiomed | $22.11 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.63 | 2020 | |
| Intuitive Surgical, INC. | $1.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.